Normally, immune checkpoints such as PD-1 and CTLA-4 pathways downregulate T cell responses to control the immune system and thus protect the body from possibly damaging responses, tumor cells can use this system to avoid immune cells’ attack through the activation of immune checkpoints and inhibition of the T cell responses (3, 4). The gene discussed is CTLA4; the disease is neoplasm.